Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
An open-label, single dose pharmacokinetic study of Xyntha (Moroctocog Alfa (AF-CC),
Recombinant Factor VIII) in male Chinese subjects with hemophilia A